13 Lorlatinibum

This tender, originating from Poland and published via the Tenders Electronic Daily (TED) platform, seeks the supply of a pharmaceutical product identified as "13 LORLATINIBUM." The core requirement is for the provision of this active pharmaceutical ingredient or finished drug product in a specific formulation: "fiolka 1200 ml" (vial of 1200 ml).

The contracting authority, managed by the Publications Office of the European Union, is procuring this item to meet its healthcare or research needs. While specific therapeutic indications are not detailed in the provided information, the nature of the product suggests a requirement for high-quality pharmaceutical-grade materials.

Typical requirements for such tenders would include adherence to stringent Good Manufacturing Practices (GMP), robust quality control and assurance procedures, and comprehensive documentation to verify product identity, purity, and potency. Bidders are expected to demonstrate their capacity to supply the specified volume reliably and consistently. Furthermore, compliance with all relevant European and national pharmaceutical regulations, including packaging, labeling, and transportation standards, will be essential. The tender will likely solicit detailed technical specifications, pricing proposals, and information on the bidder's experience and capabilities in supplying similar pharmaceutical products on a global scale.

This procurement is critical for ensuring the availability of a specific medicinal substance for its intended use.